Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Nurexone Biologic Inc (NRX.VN)

Nurexone Biologic Inc (NRX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
NurExone Plans Small-Scale of ExoPTEN Clinical Manufacturing in Preparation for FUTURE First in Human USE Pathways GlobeNewswire - Fri Dec 12, 3:04PM CST

TORONTO and HAIFA, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a preclinical-biotechnology company...

NRX.VN : 0.610 (-10.29%)
NRXBF : 0.4670 (-5.96%)
NurExone Biologic Inc. Announces Third Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire - Fri Nov 28, 8:15AM CST

TORONTO and HAIFA, Israel, Nov. 28, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc.  (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a preclinical-stage biotechnology...

NRX.VN : 0.610 (-10.29%)
NRXBF : 0.4670 (-5.96%)
NurExone Secures over C$3.18 Million Through Accelerated Warrant Exercises GlobeNewswire - Wed Nov 12, 3:02PM CST

TORONTO and HAIFA, Israel, Nov. 12, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”) is pleased to announce that, further...

NRX.VN : 0.610 (-10.29%)
NRXBF : 0.4670 (-5.96%)
NurExone Accepted into ARMI’s BioFab Startup Lab Strengthening U.S Position in Regenerative Manufacturing GlobeNewswire - Mon Nov 3, 3:04PM CST

TORONTO and HAIFA, Israel, Nov. 03, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”) announced today that it has been accepted...

NRX.VN : 0.610 (-10.29%)
NRXBF : 0.4670 (-5.96%)
NurExone Invited Presenter at Precision EV Forum in Cambridge, UK GlobeNewswire - Tue Oct 21, 3:04PM CDT

TORONTO and HAIFA, Israel, Oct. 21, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) a biopharmaceutical company developing...

NRX.VN : 0.610 (-10.29%)
NRXBF : 0.4670 (-5.96%)
NurExone Demonstrates Reproducible, Dose-Dependent Vision Recovery in Preclinical Glaucoma Model GlobeNewswire - Wed Oct 8, 7:30AM CDT

TORONTO and HAIFA, Israel, Oct. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”) a biopharmaceutical company developing...

NRX.VN : 0.610 (-10.29%)
NRXBF : 0.4670 (-5.96%)
NurExone Planning to Establish First U.S. Commercial Manufacturing Facility in Indiana GlobeNewswire - Tue Sep 16, 3:15PM CDT

TORONTO and HAIFA, Israel and INDIANAPOLIS, Sept. 16, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biopharmaceutical...

NRX.VN : 0.610 (-10.29%)
NRXBF : 0.4670 (-5.96%)
NurExone Biologic Announces Corporate Updates including Israel Patent Grant and Private Placement Closing GlobeNewswire - Thu Sep 11, 3:10PM CDT

TORONTO and HAIFA, Israel, Sept. 11, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a pioneering biopharmaceutical company...

NRX.VN : 0.610 (-10.29%)
NRXBF : 0.4670 (-5.96%)
NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness GlobeNewswire - Mon Sep 8, 3:30PM CDT

TORONTO and HAIFA, Israel, Sept. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a pioneering biopharmaceutical company...

NRX.VN : 0.610 (-10.29%)
NRXBF : 0.4670 (-5.96%)
NurExone Biologic Inc. Announces Second Quarter 2025 Financial Results GlobeNewswire - Thu Aug 28, 7:15AM CDT

TORONTO and HAIFA, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc.  (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a preclinical-stage biotechnology...

NRX.VN : 0.610 (-10.29%)
NRXBF : 0.4670 (-5.96%)

Barchart Exclusives

3 Cheapest Dividend Aristocrats for a Lifetime of Income Barchart - 1 hour ago
Three Dividend Aristocrats near their lows that analysts still say are buys. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot